EUVIMEDEUVIMED entdecken
Crossref

Clinical Implications of Background Parenchymal Enhancement on Breast MRI

Kathryn W Zamora iD, Kristen Coffey iD, Stephanie Colvin, Brittany Dashevsky, Katerina Dodelzon iD, Santo Maimone iD, Jessica H Porembka, Wenhui Zhou, Sona A Chikarmane

Journal of Breast Imaging · 05.11.2026

DOI: 10.1093/jbi/wbag059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Imaging, online erschienen am 05.11.2026. Verfasst von Kathryn W Zamora und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, Department of Radiology, Birmingham, AL, USA. Die Arbeit nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast MRI is an essential tool for breast cancer detection, evaluation, and characterization, offering greater sensitivity than mammography and ultrasound. Normal breast tissue demonstrates variable enhancement on MRI, known as background parenchymal enhancement (BPE), which reflects the physiologic enhancement of fibroglandular tissue after gadolinium administration. Initially considered an incidental finding, BPE is now recognized as a dynamic imaging feature influenced by several factors, including age, menopausal status, exogenous hormone use, and prior breast cancer treatments. Increasing evidence supports its clinical relevance since variations in BPE have been associated with differences in breast cancer risk, lesion detection, and imaging interpretation. Background parenchymal enhancement (BPE) is emerging as an important imaging biomarker with potential applications in risk stratification, evaluation of disease extent, and monitoring response to neoadjuvant therapy. Differences in BPE patterns may also correlate with tumor biology and molecular subtypes, further supporting its role in personalized breast imaging assessment. This article provides a comprehensive review of BPE, highlighting its biologic basis, imaging characteristics, and clinical implications in breast cancer care. It also examines the evolving role of artificial intelligence tools in the assessment and quantification of BPE, which may improve standardization and integration into clinical decision-making and research.

Schlagwörter

Stichwörter der Autor:innen

MRIbackground parenchymal enhancementbreast MRIbreast imaging

Autor:innen und Institutionen

  • University of Alabama at Birmingham, Department of Radiology, Birmingham, AL, USA.
  • Weill Cornell Medicine, Department of Radiology, New York, NY, USA.
  • Stanford University, Department of Radiology, Palo Alto, CA, USA.
  • Mayo Clinic, Department of Radiology, Jacksonville, FL, USA.
  • University of Texas Southwestern Medical Center, Department of Radiology, Dallas, TX, USA.
  • University of Wisconsin, Department of Radiology, Madison, WI, USA.

ORCID-Profile: Kathryn W Zamora, Kristen Coffey, Katerina Dodelzon, Santo Maimone

Zitieren

APA

Zamora, K. W., Coffey, K., Colvin, S., Dashevsky, B., Dodelzon, K., Maimone, S., Porembka, J. H., Zhou, W., & Chikarmane, S. A. (2026). Clinical Implications of Background Parenchymal Enhancement on Breast MRI. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbag059

Vancouver

Zamora KW, Coffey K, Colvin S, Dashevsky B, Dodelzon K, Maimone S, et al. Clinical Implications of Background Parenchymal Enhancement on Breast MRI. Journal of Breast Imaging. 2026. doi:10.1093/jbi/wbag059

BibTeX
@article{Zamora2026,
  author = {Zamora, Kathryn W and Coffey, Kristen and Colvin, Stephanie and Dashevsky, Brittany and Dodelzon, Katerina and Maimone, Santo and Porembka, Jessica H and Zhou, Wenhui and Chikarmane, Sona A},
  title = {Clinical Implications of Background Parenchymal Enhancement on Breast MRI},
  journal = {Journal of Breast Imaging},
  year = {2026},
  doi = {10.1093/jbi/wbag059}
}
Kostenlos starten →